Back
Minerva Neurosciences 10K Form
Sell
33
NERV
Minerva Neurosciences
Last Price:
2.53
Seasonality Move:
30.25%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive NERV News And Ratings
See the #1 stock for the next 7 days that we like better than NERV
NERV Financial Statistics
Sales & Book Value
Annual Sales: | $41.18M |
---|---|
Cash Flow: | $-5.99M |
Price / Cash Flow: | 0 |
Annual Sales: | $-4.07 |
Price / Book: | 0 |
Profitability
EPS (TTM): | -4.66000 |
---|---|
Net Income (TTM): | $-30.01M |
Gross Margin: | $0 |
Return on Equity: | 0% |
Return on Assets: | 0% |
Minerva Neurosciences Earnings Forecast
Key Minerva Neurosciences Financial Ratios
- The Selling, General & Administrative Expenses for NERV have been equal to 41.99% of Gross Profit Margin.
- The Interest Expense is -27.60% of Operating Income.
- Per Share Earnings over the last 12 years have been positive in 6 years.
Minerva Neurosciences Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Biotechnology |
Sector: | Healthcare |
Current Symbol: | NERV |
CUSIP: | 603380 |
Website: | minervaneurosciences.com |
Debt
Debt-to-Equity Ratio: | 0 |
---|---|
Current Ratio: | 0 |
Quick Ratio: | 0 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |
NERV Technical Analysis vs Fundamental Analysis
Sell
33
Minerva Neurosciences (NERV)
is a Sell
Is Minerva Neurosciences a Buy or a Sell?
-
Minerva Neurosciences stock is rated a Sell
The current Minerva Neurosciences [NERV] share price is $2.50. The Score for NERV is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.